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Available online 09 November 2016Systemic sclerosis (SSc) patients are at high risk for the development of ischemic digital ulcers (DUs). The aim of
this study was to assess in SSc patients a correlation between skin perfusion evaluated by LDPI and DUs and to
evaluate the prognostic value of skin perfusion to predict the new DUs occurrence.
Fifty eight (47 female, 11 male) SSc patients were enrolled. Skin perfusion of hands and region of interest (ROIs)
was measured by Laser Doppler perfusion Imager (LDPI). The proximal-distal gradient (PDG) was present when
the perfusion mean difference between ROI1 and ROI2 was N30 pU.
The skin perfusion of hands is lower in SSc patients than in healthy controls. The skin perfusion decreased with
severity of capillaroscopic damage. Both mean perfusion of hand and PDG are significantly (p b 0.01 and
p b 0.0001, respectively) lower in SSc patients with new DUs than in SSc patients without DUs. Only 2 of 11
SSc patients (18.2%) with PDG developed new digital ulcers, conversely 36 of 47 (76.6%) SSc patients without
PDG developed new digital ulcers (p b 0.001). The ROC curves demonstrated a good accuracy of newDUs predic-
tion for PDG (0.78, p b 0.0001). Using this cut-off value of 30 pU, RR for new DUs development in SSc patients
without PDG is 4,2 (p b 0.001).
LDPI indices could be used in association to the capillaroscopic and clinical findings or serological tests in the
identification of patients at high risk of developing DUs.
© 2016 Elsevier Inc. All rights reserved.Keywords:
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Systemic sclerosis (SSc) is an autoimmune disease characterized by
endothelial dysfunction and fibrosis of the skin and internal organs. En-
dothelial dysfunction,microvascular andmacrovascular damage are the
hallmarks of SSc (Campbell and LeRoy, 1975; Rosato et al., 2011a).
Patients with SSc are at high risk for the development of ischaemic
digital ulcers (DUs), which occur in 35% to 60% of SSc patients
(Matucci-Cerinic et al., 2011). The early detection of patients with a
high risk of developing DUs could allow a preventive treatment of
these complications, with a reduction of morbidity and social costs.
Nailfold videocapillaroscopy (NVC) represents the best method to eval-
uate digital capillaroscopic damage. Capillaroscopic skin ulcer risk index
(CSURI)may represent a novel tool with the ability to predict the devel-
opment of DUs in SSc patients (Sebastiani et al., 2009).
Laser Doppler Perfusion Imager (LDPI) is a method used to evaluate
hand skin perfusion in patients with primary and secondary Raynaud's
phenomenon (Rosato et al., 2009; Cracowski and Roustit, 2016).Rome, Department of ClinicalA negative correlation exists between nailfold microvascular dam-
age severity and fingertip blood perfusion (Sulli et al., 2014). A negative
correlation between skin perfusion and digital artery pulsatility was ob-
served (Rosato et al., 2011b). With the progression of capillaroscopic
damage the abnormal microvascular response to cold stimulation, eval-
uated by LDPI, appears in the hand dorsum skin (Rosato et al., 2011c).
The aim of this study was to asses in SSc patients a correlation be-
tween skin perfusion evaluated by LDPI and DUs and to evaluate the
prognostic value of skin perfusion to predict the new DUs occurrence.
2. Materials and methods
2.1. Patients
Fifty eight (47 female and 11 male; mean age 48.8 ± 15.3 years)
consecutive patients with SSc were enrolled in this study. All patients
met the American College of Rheumatology/European League criteria
for classification and diagnosis of SSc (van den Hoogen et al., 2013).
Mean duration of Raynaud's phenomenon (RP) and mean duration of
disease were 10.8 ± 5.5 years and 8.4 ± 5.4 years, respectively. Thir-
ty-four patients had limited cutaneous SSc (lcSSc) and 24 had diffuse
cutaneous SSc (dcSSc) as defined by Le Roy et al. (LeRoy et al., 1998).
Table 1 showed the SSc patients' epidemiological and clinical features.
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perlipidaemia, cardiac failure, cardiac valve diseases (insufficiency or
stenosis of aortic and mitralic valve), hepatic failure, diabetes, cerebro-
vascular diseases, peripheral vascular diseases, coagulopathy, smokers,
pregnant or breastfeeding women were excluded. SSc patients with ac-
tive digital ulcers at baselinewere excluded from this study.We did not
consider as eligible for the work patients with ulcers on the extension
faces and related to calcinosis. All patients were taking nifedipine at a
stable dose (30mg/day) for at least threemonths. Only patientswho re-
ceive a stable therapy with Bosentan (250 mg/day) for 6 months were
enrolled in the present study. Patients in current therapywith phospho-
diesterase-5 inhibitors and endothelin receptor antagonists for pulmo-
nary arterial hypertension, prior sympathectomy of the upper limb
were excluded. None of patients were treatedwith immunosuppressive
agents (e.g., cyclophosphamide or mycophenolate mofetil). After LDPI
examination, the patients were examined for the appearance of new
DUs after 3, 6, 9 and 12 months of follow-up without any changes in
previous treatments.
Thirty (26 female and 4 male, mean age 46 ± 11.5 years) healthy
controls (HC)were also recruited. The subjects' written consentwas ob-
tained according to the Declaration of Helsinki and the study was ap-
proved by ethics committee of Sapienza University.
2.2. Laser Doppler Perfusion Imager (LDPI) and nailfold videocapillaroscopy
(NVC)
LDPI and NVC were performed after resting the subject in a temper-
ature controlled room at 24 ± 0.4 °C for 20 min. Patients and healthy
controls did not drink alcoholic beverages and coffee for two days be-
fore the examination. The investigator who analyzed the LDPI was
blinded for NVC findings.
2.3. LDPI assessment
Calcium channel blockers therapy was discontinued 72 h before the
LDPI. Patients in therapy with iloprost underwent to LDPI examination
the day before the next infusion. Baseline perfusion of hands dorsal re-
gion was registered by laser speckle contrast analysis device (PeriCam
PSI, Perimed, Sweden). Themean perfusion has been expressed by arbi-
trary perfusion units (pU), which are directly proportional to the prod-
uct of the mean speed and the concentration of red blood cells.
According to our previous studies, the dorsum of hand was divided in
three regions of interest (ROI). ROI 1 included three fingers of the
hand from the second to the four distally to proximal interphalangeal
finger joint. ROI 2 included the area between the proximal interphalan-
geal and the metacarpophalangeal joint. ROI 3 included only the dorsal
surface of the hand without the fingers. The proximal-distal gradientTable 1
SSc patients' epidemiological and clinical features.
Sex (female/male) 47/11
Age, years 48.8 ± 15.3
Disease duration, years 8.4 ± 5.4
mRSS 11 ± 5.7
dcSSc/lcSSc 34//24
SSc-specific autoantibodies, n (%)
Anti-topoisomerase I 35 (60.4)
Anticentromere 16 (27.6%)
None 7 (12%)
Patients with digital ulcers history, n (%) 40 (70%)
Patients with new digital skin ulcers, n (%) 38 (65.5%)
Number of digital ulcers/patients 1.9 ± 2.5
Capillaroscopic pattern, n (%)
Early 15 (25.9)
Active 21 (36.2)
Late 22 (37.9)was present when the perfusion mean difference between ROI 1 and
ROI 2 was N30 pU (Rosato et al., 2009; Rosato et al., 2011c).
2.4. NVC
NVC was performed with a videocapillaroscope (Pinnacle Studio
version 8) equipped with a 500 × optical probe. The nailfold of the sec-
ond, third, fourth and fifth fingerwas examined in each patient. Accord-
ing to Cutolo et al. the patterns identified within the “SSc pattern”
include: early, active and late (Cutolo et al., 2006).
2.5. Statistical analysis
All the resultswere expressed asmeanand standard deviation. Com-
mercially software (SPSS version 21.0) was used for statistical analysis.
The coefficient of skewness and coefficient of kurtosis were used to
evaluate normal distribution of data. Multivariate analysis was applied
for the estimation of relationship of Doppler indices with clinical fea-
tures (e.g. age, duration of disease). A receiver operating characteristic
(ROC) curve analysis was performed to analyze the prognostic accuracy
of each Doppler indices in regard to ulcer development. Group compar-
isonsweremade by Student's unpaired 2-tailed t-test. Pearson product-
moment correlation coefficient (r) was used to test for an association
between numerical variables. The chi-square test or Fisher's exact test,
as appropriate, were used to compare categorical variables. Relative
risk (RR) and 95% confidence intervals (95% CI) are reported. Compari-
sons between the three NVC patterns were by non parametric Kruskal-
Wallis test and the data were expressed as median and range. P-
values b 0.05 were considered significant.
3. Results
In SSc patients the mean perfusion is significantly (p b 0.01) lower
than in HC (39 ± 2.1 pU vs 49.9 ± 13.9 pU). The mean perfusion of
ROI 1 and ROI 2 is significantly lower in SSc patients than HC. A signifi-
cant difference of mean perfusion was observed in ROI 3 (Table 2). The
PDG is significantly higher (p b 0.0001) in HC than in SSc patients
(50.3 ± 11.9 vs−0.19 ± 41.1) (Table 2). The PDG is present in 100%
of HC and in 18.9% of SSc patients (p b 0.0001).
In three capillaroscopic groups (early, active and late) themeanvalues
of perfusion were different. In early and active capillaroscopic groups the
mean perfusion of hand is significantly (p b 0.0001) higher than in late
capillaroscopic group (Table 3). The mean values of perfusion of ROI 1
and ROI 2 significantly decreasedwith severity of capillaroscopic damage.
Themean values of perfusion of ROI 3 did not show any significant differ-
ences between early and active capillaroscopic groups. Therefore the
mean value of ROI 3 perfusion is significantly lower (p b 0.0001) in late
capillaroscopic group than in early and active capillaroscopic groups.
The PDG significantly (p b 0.01) decreased with capillaroscopic severity
damage (Table 3). The PDG is present in 10 of 15 (66.7%) early SSc pa-
tients, in 1 of 21 (4.8%) active SSc patients and in none of 22 late SSc
patients.
The principal features of SSc patients with or without new DU were
showed in Table 4. Within 12months since basal LDPI assessment 38 of
58 patients (44.8%) experienced new DUs. The new DU are moreTable 2
Mean perfusion, expressed as perfusion unit (pU), of hand and region of interest (ROIs) in
SSc patient and healthy controls. The proximal-distal gradient (PDG) was expressed by
perfusion mean difference between ROI1 and ROI2.
SSc patients Healthy controls p
Hand (pU) 39 ± 2.1 49.9 ± 13.9 p b 0.01
ROI 1 (pU) 71.7 ± 41.5 128.9 ± 26.2 p b 0.0001
ROI 2 (pU) 66.6 ± 37.7 97.5 ± 38.8 p b 0.0001
ROI 3 (pU) 72.9 ± 41.9 78.7 ± 26 p N 0.05
PDG −0.19 ± 41.1 50.3 ± 11.9 p b 0.0001
Table 3
Mean perfusion, expressed as perfusion unit (pU), of hand and region of interest (ROIs) in three capillaroscopic groups. The proximal-distal gradient (PDG) was expressed by perfusion
mean difference between ROI1 and ROI2.
Early Active Late p
Hand (pU) 45.2 (24.5–64.7) 46.8 (22.3–114) 17.6 (8.1–60.3) p b 0.0001
ROI 1 (pU) 108.7 (60.0.8–158.6) 78.2 (36.4–167.7) 29.3 (11–125.8) p b 0.0001
ROI 2 (pU) 87.3 (42.5–124.1) 66.7 (29.7–175) 28.4 (11.9–96.2) p b 0.0001
ROI 3 (pU) 68.8 (39–121.6) 74.4 (32.1–204) 43.7 (15.1–136.1) p N 0.05
PDG 34.9 (−61.2–57.5) −8.3 (−134.4–92.2) −3.5 (−38.4–99.5) p b 0.01
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lcSSc (20.7%). The occurrence of newDUs is higher (p N 0.05) in patients
with anti-topoisomerase I antibodies (40.3%) than in patients with
others autoantibodies (22.4%). The new DUs occurrence is higher
(p b 0.0001) in SSc patients with DUs history (62.1%) than in SSc pa-
tients without DUs history (3.4%). The new DU are more frequent
(p b 0.0001) in patients with active and late capillaroscopic pattern
than in patients with early capillaroscopic pattern (Table 4). Sixteen of
19 patients (27.6%) treated with Bosentan developed new DUs, 30 of
43 (69.8%) patients treated with intravenous Ioprost developed new
DUs and 12 of 14 (20.7%) patients treated with Bosentan and intrave-
nous Iloprost developed new DUs.
The values of perfusion in SSc patients with new digital ulcers and in
SSc patients without new digital ulcers are reported in Table 4. The
mean perfusion of hand is significantly (p b 0.01) lower in SSc patients
with new DUs than in SSc patients without DUs [38 (8.15–114) vs 41.2
(14.9–74.8)]. Any significant difference of mean perfusion of ROIs was
observed between SSc patients with new DUs and SSc patients without
DUs. The PDG is significantly lower (p b 0.0001) in SSc patients with
new DUs than in SSc patients without new DUs [−13.7(−134.4–
57.5) vs 25.5 (−32.3–99.5)]. Only 2 of 11 SSc patients (18.2%) with
PDG developed new digital ulcers, conversely 36 of 47 (76.6%) SSc pa-
tients without PDG developed new digital ulcers (p b 0.001).
The ROC curves demonstrated a good accuracy of new DUs predic-
tion for PDG (0.78, p b 0.0001 95% CI 0.66–0.91). Using this cut-off
value of 30 pU, RR for new DUs development in SSc patients without
PDG is 4.2 (95% CI 1.2–14.9 p b 0.001).
4. Discussion
In this studywe demonstrated that skin perfusion of dorsal region of
hands is lower in SSc patients than healthy controls. In SSc patients
the skin perfusion decreases progressively with the severity of
capillaroscopic damage. The SSc patients with absence of PDG showed
an increased risk of DUs occurrence.
In SSc patients various author reported that the skin perfusion, evac-
uate by LDPI, is reduced in SSc patients and it correlated withTable 4
Clinical features of SSc patients with or without new digital ulcers (DU) and mean perfusion of
Patient with new D
DU history Yes 36 (62.1)
No 2 (3.4)
Subset dcSSc 26 (44.8)
lcSSc 12 (20.7)
Autoantibodies Anti-topoisomerase I 25 (40.3)
Others 13 (22.4)
Capillaroscopy Early 5 (8.6)
Active 12 (20.7)
Late 21 (36.2)
Mean perfusion Hand (pU) 38 (8.15–114)
ROI 1 (pU) 61.1 (11–167.7)
ROI 2 (pU) 65.2 (11.9–175)
ROI 3 (pU) 76 (15.1–204)
PDG −13.7 (−134.4–5
lcSSc: limited cutaneous systemic sclerosis; dcSSc: diffuse cutaneous systemic sclerosis. pU: pe
PDG: proximal-distal gradient, expressed by perfusion mean difference between ROI 1 and ROprogression of NVC patterns of microangiopathy (Rosato et al., 2009;
Sulli et al., 2014; Rosato et al., 2011c; Ruaro et al., 2014a). With the
capillaroscopic damage severity the skin perfusion worsens also in
hand dorsum of hands (Rosato et al., 2011c). The skin perfusion showed
a negative correlation with digital arteries pulsatility, evaluated by
photopletismography, and with ecocolorDoppler indices of digital arte-
rial stiffness (Rosato et al., 2011a).
Patients with SSc are at high risk for the development of ischaemic
DUs, which occur in 35% to 60% of patients with SSc. However no sero-
logical or clinical markers have been proven safe in predicting the new
DUs occurrence. Many authors have tried to identify markers that may
be predictive for the development of new DUs.
The early occurrence and the high frequency of DUs complications
are especially seen in patients with dcSSc and/or anti-topoisomerase
antibodies. Male patients with early onset SSc,more severe skin fibrosis,
impaired DLCO, and anti-topoisomerase I were most likely to exhibit
prior or current DUs (Denton et al., 2012; Tiev et al., 2009). An observa-
tional cohort study of patients with pulmonary arterial hypertension
(PAH) andmultiple DUs at diagnosis were associatedwith future occur-
rence of DUs (Brand et al., 2015).
Avouac et al. identified high placental growth factor serum levels
and low circulating endothelial progenitor cells counts as predictors of
new DUs in SSc. It highlights the critical role of angiogenesis in this vas-
cular outcome. These markers may improve DUs risk stratification and
therefore allow earlier therapeutic intervention (Avouac et al., 2012).
DUs occurrence was associated to capillaroscopic damage. Cutolo et
al. demonstrated that skin DUs seem to be associated with the “late”
NVC pattern, characterized by avascular areas (severe capillary loss)
(Cutolo et al., 2010). Sebastiani et al. demonstrated that the proposed
CSURImay represent a novel toolwith the ability to predict thedevelop-
ment of DUs in SSc patients. The development and validation of new
outcome measures may facilitate the recognition of patients at high
risk to develop DUs and may improve the monitoring of vascular com-
plications and treatments (Sebastiani et al., 2009).
Rosato et al. demonstrated that intrarenal arterial stiffness, evaluat-
ed by renal ecocolorDoppler, represents are reliable markers of new
DUs occurrence. Doppler indices could be used in association with thehand and region of interest (ROIs) in SSc patient with or without new digital ulcers (DUs).
U n (%) Patients without new DU n (%)
4 (6.9)
16 (27.6)
8 (13.8)
12 (20.7)
10 (17.2)
10 (17.2)
10 (17.2)
9 (15.5)
1 (1.7)
41.2 (14.9–74.8) p b 0.01
91.8 (29.2–158.6) p N 0.05
69.1 (22.5–124.1) p N 0.05
67.2 (42.5–104.9) p N 0.05
7.5) 25.5 (−32.3–99.5) p b 0.0001
rfusion unit.
I 2.
4 B. Barbano et al. / Microvascular Research 110 (2017) 1–4capillaroscopic and clinical findings or serologic tests for the identifica-
tion of patients at high risk of developing DUs (Rosato et al., 2014).
In the assessment of skin perfusion and for the monitoring of digital
ulcers, LSCI is a useful tool, even if not superior to LDPI at the moment
(Ruaro et al., 2014b; Gaillard-Bigot et al., 2014; Ruaro et al., 2015).
Even the distal dorsal difference, a parameter derived from thermogra-
phy, has been used to differentiate primary RP from SSC (Anderson et
al., 2007).
For thefirst timewedemonstrated that the PDG represents a reliable
marker to predict new DUs in SSc patients. In our study group skin per-
fusion is reduced in SSc patients with new DUs compared to patients
without newDUs. PDG showed a good accuracy of newDUspredictions.
Since LDPI indices are an easy tool, we could assume that the LDPI in-
dices could be used in association to the capillaroscopic and clinical
findings or serological tests in the identification of patients at high risk
of developing DUs. We can conclude that LDPI indices of skin perfusion
are reliablemarkers of newDU occurrence. Therefore, larges studies are
needed to confirm our preliminary data.
5. Conclusions
In SSc patients the skin perfusion decrease with severity of
capillaroscopic damage.
Bothmean perfusion of hand and PDG are significantly (p b 0.01 and
p b 0.0001, respectively) lower in SSc patients with newDUs than in SSc
patients without DUs.
LDPI indices could be used in association to the capillaroscopic and
clinical findings or serological tests in the identification of SSc patients
at high risk of developing DUs.
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